Zuojun Xu

Nintedanib in patients with progressive fibrosing interstitial lung diseases—subgroup analyses by interstitial lung disease diagnosis in the INBUILD trial: a randomised, double-blind, placebo-controlled, parallel-group trial

Athol U. Wells, Kevin R. Flaherty, Kevin K. Brown et al. · The Lancet Respiratory Medicine · 2020 · 522 citations · Full text

Inbuild Trial, Parallel-group Trial, Advanced Lung Disease +5

Plasminogen activator inhibitor-1 deficiency protects against atherosclerosis progression in the mouse carotid artery

Daniel T. Eitzman, Randal J. Westrick, Zuojun Xu et al. · Blood · 2000 · 180 citations

Spontaneous thrombosis in mice carrying the factor V Leiden mutation

Jisong Cui, Daniel T. Eitzman, Randal J. Westrick et al. · Blood · 2000 · 134 citations

Non-invasive Imaging of Idiopathic Pulmonary Fibrosis Using Cathepsin Protease Probes

Nimali P. Withana, Xiaowei Ma, Helen M. McGuire et al. · Scientific Reports · 2016 · 117 citations · Full text

Imbalance between Th17 and Regulatory T-Cells in Sarcoidosis

Hui Huang, Zhiwei Lu, Chunguo Jiang et al. · International Journal of Molecular Sciences · 2013 · 99 citations · Full text

Clinical Immunology, Immunodeficiencies, T-regulatory Cell +23